GL1X · GenesisL1 explorer

Research workbench

Crystal structure of SARS-Cov-2 main protease Y54C mutant in complex with PF00835231

Analyse Crystal structure of SARS-Cov-2 main protease Y54C mutant in complex with… in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
8J3A
Type
protein
Length
572 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v2 / PDB Bank
Contract
0xd58B01f6C18086e5202cdC5D7Ad3E41790360102
Owner
0xF4e1AA6f26B7DA48EeAD9B24a97927303eeA07b8
Resolution
1.91
Source
Severe acute respiratory syndrome coronavirus 2
Molecule
3C-like proteinase nsp5
EC
3.4.22.69
UniProt
P0DTC1
Ligands
V2M
Pockets
7 · best druggability 0.74

Structure

x-ray diffraction · resolution 1.91 · 2 distinct chains · 25% helix, 31% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
A3C-like proteinase nsp5 (EC 3.4.22.69)protein28224% helix, 32% strandP0DTC1
B3C-like proteinase nsp5 (EC 3.4.22.69)protein29025% helix, 30% strandP0DTC1

Ligands and binding sites

  • V2M · N-[(2S)-1-({(2S,3S)-3,4-dihydroxy-1-[(3S)-2-oxopyrrolidin-3-yl]butan-2-yl}amino)-4-methyl-1-oxopentan-2-yl]-4-methoxy-1H-indole-2-carboxamide · ligand · 2 copies · chains A, B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

7 pockets found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
16900.740.8063empty
21110.450.7926empty
3970.440.7920empty
41090.390.7522V2M
51270.380.7420V2M

Interfaces

1 interface between chains.

  • A–B · 999 Ų buried · 22 hydrogen bonds · protein-protein

Modifications

Observed in the structure: 2 covalent (covalent ligand).

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.